Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Posted on by ScienceFather

Mrs. Beatriz Estalayo Gutiérrez | Medicine and Dentistry | Best Research Article Award

Médico de Familia at SERMAS, Spain

Beatriz Estalayo Gutiérrez, a Family Physician with a PhD in Medicine, is a strong candidate for the Best Research Article Award due to her innovative research in mental health, specifically through auditory interventions in primary care. Her work, including the development of the Frequency Modulated Auditory Intervention, addresses anxiety and depression using novel auditory modulation techniques, which have been evaluated in controlled clinical trials and published in reputable journals. Her academic credentials are complemented by significant international experience with Médecins Sans Frontières, where she provided care in conflict zones. While her research has had an important impact, her citation index (H-index of 2) suggests potential for broader influence, and she could benefit from more collaborative research efforts and increased visibility at international conferences. Nevertheless, her contributions to the field of mental health, especially in low-resource settings, make her a deserving candidate for the award.

Professional Profile 

Education🎓

Beatriz Estalayo Gutiérrez holds a PhD in Medicine from the University of Alcalá, completed between 2016 and 2021, where she focused on anxiety and depression in primary care, specifically through auditory interventions. In addition to her doctoral studies, she earned a Master’s Degree in Humanitarian Medicine from CEIC, Complutense University (2006-2007), and a Diploma in Epidemiology and Public Health from Rey Juan Carlos University (2004-2007). She also holds a Bachelor’s Degree in Medicine from UAM, obtained between 1997 and 2003. Her academic training blends medical practice with research, particularly in the fields of mental health and humanitarian medicine. This diverse educational background has equipped her with a deep understanding of both clinical and research aspects of medicine, allowing her to contribute significantly to the study of mental health interventions in primary care settings. Beatriz’s education has laid a strong foundation for her ongoing work in medical research and healthcare.

Professional Experience📝

Beatriz Estalayo Gutiérrez has extensive professional experience as a family physician, with over 16 years of practice in primary care since 2004. She has been a key part of the SERMAS Servicio Madrileño de Salud since 2007, where she has honed her expertise in family medicine, focusing on mental health issues. In addition to her work in Spain, Beatriz has gained significant international experience through her involvement with Médecins Sans Frontières (MSF). She has worked in various crisis regions, including the Turkey-Syria border, the Tunisia-Lebanon border, Port-au-Prince, Haiti, and Madaoua, Niger, providing medical care to displaced populations and those affected by epidemics and natural disasters. This diverse experience has provided her with a global perspective on healthcare delivery in low-resource settings. Beatriz’s combination of clinical experience and humanitarian work has enriched her approach to patient care, particularly in addressing mental health challenges in underserved communities.

Research Interest🔎

Beatriz Estalayo Gutiérrez’s research interests primarily focus on mental health, particularly in primary care settings. Her work explores innovative approaches to treating anxiety and depression, with a specific emphasis on auditory interventions. Beatriz has developed and evaluated the Frequency Modulated Auditory Intervention, which has been tested in controlled clinical trials to assess its effectiveness in modulating auditory perception and improving mental health outcomes. Her research aims to bridge the gap between sensory processing and mental health therapies, highlighting the potential of auditory modulation techniques in treating common mental health conditions. Additionally, Beatriz is interested in the interplay between auditory perception asymmetries and mental health disorders, such as anxiety and depression. Her work contributes to a deeper understanding of how auditory interventions can be used as a therapeutic tool in primary care, offering new insights into improving the mental well-being of patients, especially in underserved populations.

Award and Honor🏆

Beatriz Estalayo Gutiérrez has not yet received major formal awards or honors, but her work has been recognized in the academic and medical communities, particularly for her innovative contributions to mental health research. Her publications, including her research on auditory interventions in the treatment of anxiety and depression, have been published in reputable journals such as the Journal of Clinical Medicine and Symmetry, contributing to her growing recognition in the field of primary care and mental health. Her research has also been cited internationally, indicating a growing influence in the medical and scientific communities. Although she has not yet received a specific award, her continuous academic and professional contributions demonstrate her commitment to advancing healthcare, particularly in the intersection of sensory processing and mental health. Her dedication to improving patient care, especially in underserved settings, highlights her potential for future recognition and awards in the medical research field.

Research Skill🔬

Beatriz Estalayo Gutiérrez possesses strong research skills, particularly in the areas of clinical trials, mental health interventions, and auditory perception. Her ability to design and conduct controlled and randomized clinical trials is evident in her work on the Frequency Modulated Auditory Intervention, which targets anxiety and depression in primary care settings. She demonstrates expertise in data analysis and the development of innovative intervention techniques that bridge sensory processing with mental health treatment. Beatriz’s interdisciplinary knowledge spans from clinical medicine to public health and epidemiology, allowing her to apply diverse methodologies in her research. Her proficiency in publishing findings in peer-reviewed journals further showcases her ability to communicate complex research outcomes effectively to the global scientific community. Additionally, her experience with international humanitarian missions, such as those with Médecins Sans Frontières, adds a unique perspective to her research, particularly in addressing mental health in low-resource and crisis settings.

Conclusion💡

Beatriz Estalayo Gutiérrez is a highly promising candidate for the Best Research Article Award, with her innovative approach to addressing mental health issues through auditory interventions in primary care. Her work has the potential to reshape mental health treatments, particularly in low-resource settings. However, there is room for growth in her citation index and in expanding her collaborative research efforts. Overall, her research has substantial value in both academic and clinical contexts, making her a strong contender for the award.

Publications Top Noted✍️

  • Authors: Beatriz Estalayo-Gutiérrez, María José Álvarez-Pasquín, Francisco Germain

  • Year: 2025

  • Title: Approach to Mental Health Through a Frequency Modulated Auditory Intervention: A Controlled and Randomized Clinical Trial

  • Journal: Journal of Clinical Medicine

  • DOI: 10.3390/jcm14010288

Liat Waldman Radinsky | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liat Waldman Radinsky | Medicine and Dentistry | Best Researcher Award

Sheba Medical Center, Israel

Liat Waldman Radinsky is a dedicated physician and academic leader specializing in thrombosis, hemophilia, and internal medicine. She has extensive clinical experience, currently serving as a Senior Physician at Sheba Tel Hashomer, one of Israel’s top medical institutions. Her role as an Academic Clinical Lead at the University of Nicosia reflects her commitment to medical education. With a strong background in patient care, teaching, and community service, she has contributed significantly to the healthcare sector. Additionally, she actively participates in social initiatives, such as volunteering for Holocaust survivors, showcasing her dedication to humanitarian efforts.

Professional Profile 

Education

Liat Waldman Radinsky earned her M.D. from Ben-Gurion University of the Negev (2012-2015), following a B.Sc. in Medical Sciences from the same institution (2009-2012). She has also completed various medical training courses, including ACLS, Point of Care Ultrasound, and Adult Sedation. Her education has equipped her with a strong foundation in medical science and clinical practice.

Professional Experience

Liat has held multiple roles in prestigious medical institutions. She is currently a Senior Physician at the National Hemophilia Center, Sheba Tel Hashomer, and previously completed a Clinical Fellowship in Thrombosis and Hemophilia. Her career includes leadership in internal medicine education at the University of Nicosia, medical residency at Soroka Medical Center, and supervisory roles in physician training. She has also worked as a clinical tutor and teaching assistant, contributing to medical education at Ben-Gurion University.

Research Interest

Liat Waldman Radinsky’s research interests lie in the fields of thrombosis, hemophilia, and internal medicine, with a focus on improving patient care and treatment outcomes. Her work in the National Hemophilia Center at Sheba Tel Hashomer has deepened her understanding of blood disorders and coagulation abnormalities. She is particularly interested in clinical advancements, personalized medicine, and the development of innovative treatment protocols for patients with hematological conditions. Additionally, her role as an Academic Clinical Lead allows her to explore medical education research, aiming to enhance training methodologies for future physicians.

Awards and Honors

Throughout her medical career, Liat Waldman Radinsky has been recognized for her excellence in clinical practice and education. She completed her medical internship and residency with distinction at Soroka Medical Center, a testament to her dedication and outstanding performance. Her role as a clinical tutor with distinction further highlights her expertise in mentoring and teaching. Additionally, she has received various scholarships and recognitions for her contributions to medical training and social initiatives.

Research Skills

Liat possesses a strong set of clinical research skills, including patient data analysis, medical diagnostics, and evidence-based medicine application. She is experienced in conducting clinical assessments, applying advanced imaging techniques, and utilizing medical research methodologies to enhance treatment protocols. Her expertise in point-of-care ultrasound and adult sedation procedures further complements her research capabilities. Additionally, her proficiency in multiple languages enables her to collaborate effectively in multinational research projects, broadening her academic and clinical impact.

Conclusion

Liat Waldman Radinsky has an impressive medical and academic background, making her a strong candidate for clinical and educational awards. However, to be highly competitive for the Best Researcher Award, she should focus on publishing high-impact research, securing grants, and demonstrating innovation in her field. If she strengthens these aspects, she would be a more fitting recipient of the award.

Publications Top Noted

Title: Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

Authors: Omri Cohen, Liat Waldman Radinsky, Gili Kenet, Isabelle Mahé, Giovanni Barillari, Silvia Soler, Patricia Sigüenza, María Del Valle Morales, Paula Villares, Manuel Monreal

Year: 2024

Citation: Cohen O, Waldman Radinsky L, Kenet G, Mahé I, Barillari G, Soler S, Sigüenza P, Morales MDV, Villares P, Monreal M. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia. Blood Advances. 2024; DOI: 10.1182/bloodadvances.2024012611.

Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mrs. Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Supervising Medical Laboratory Technologist at Zibo Central Hospital, China

Mrs. Wenxiu Tian is an accomplished Supervising Medical Laboratory Technologist at the Center of Translational Medicine, Zibo Central Hospital, with a strong academic and research background in oncology and molecular biology. Holding a Master’s degree from Shandong Second Medical University, she has demonstrated her expertise through the publication of 9 SCI-indexed papers, including multiple first-author and corresponding-author contributions. Her research focuses on the molecular mechanisms of melanoma, nasopharyngeal carcinoma, and pancreatic cancer, with particular emphasis on ferroptosis and lipid metabolism, contributing to advancements in cancer therapeutics. Mrs. Tian has also led a Shandong Provincial Medical and Health project and received the Youth Talent Award from Zibo Central Hospital in recognition of her contributions. With collaborative publications, successful project funding, and an ongoing patent application, Mrs. Tian continues to play a key role in translational cancer research, combining innovative approaches with strong scientific rigor to improve cancer diagnostics and treatment.

Professional Profile 

Education

Mrs. Wenxiu Tian holds a Master’s degree in Biochemistry and Molecular Biology from Shandong Second Medical University, earned between 2019 and 2022. During her postgraduate studies, she focused extensively on molecular oncology, particularly exploring mechanisms related to cancer pathogenesis and potential therapeutic targets. Her academic training equipped her with advanced laboratory techniques, data analysis skills, and a deep understanding of cellular and molecular processes underlying cancer development. During her Master’s program, Mrs. Tian actively engaged in research, resulting in the publication of 4 SCI papers, including 2 as first author, demonstrating her ability to lead and contribute to high-impact scientific work. Her academic foundation combines strong theoretical knowledge with practical research expertise, preparing her for a successful career in translational medicine. This solid educational background has enabled her to excel in her current role at Zibo Central Hospital, where she continues to integrate academic research with clinical applications.

Professional Experience

Mrs. Wenxiu Tian has accumulated over 10 years of professional experience in the field of medical laboratory technology and translational medicine, with a focus on oncology research. She began her career in 2015 at Zibo Central Hospital, where she currently serves as a Supervising Medical Laboratory Technologist in the Center of Translational Medicine. In this role, she leads molecular biology research projects, conducts advanced laboratory diagnostics, and collaborates with clinical teams to apply research findings to patient care. Throughout her career, Mrs. Tian has demonstrated strong expertise in cancer biomarker discovery, ferroptosis mechanisms, and lipid metabolism in tumors, contributing to improved understanding of melanoma, nasopharyngeal carcinoma, and pancreatic cancer. Her work has resulted in multiple SCI publications, a provincial research project, and a patent under development. Mrs. Tian’s blend of technical laboratory skills, research leadership, and commitment to advancing cancer diagnostics and treatment makes her a valuable asset to the medical and scientific community.

Research Interest

Mrs. Wenxiu Tian’s research interests lie primarily in the field of oncology, with a particular focus on understanding the molecular mechanisms driving cancer progression and treatment resistance. Her work centers on exploring ferroptosis, a newly recognized form of programmed cell death, and its role in cancers such as melanoma, nasopharyngeal carcinoma, and pancreatic cancer. She is especially interested in the interplay between lipid metabolism and tumor microenvironments, aiming to identify novel molecular biomarkers and therapeutic targets for early diagnosis and personalized cancer treatment. Mrs. Tian also investigates the role of tumor suppressor genes, oncogenes, and signaling pathways in regulating cancer cell survival, proliferation, and metastasis. Her research integrates basic molecular biology techniques with translational applications, bridging the gap between benchside discoveries and bedside care. With an emphasis on collaborative, multi-disciplinary research, she aims to contribute to the development of more effective, targeted therapies to improve cancer outcomes.

Award and Honor

Mrs. Wenxiu Tian has received recognition and honors for her outstanding contributions to cancer research and translational medicine. One of her most notable achievements is being awarded the prestigious “Youth Talent” title by Zibo Central Hospital, acknowledging her exceptional work in molecular oncology research and her leadership in advancing innovative approaches to cancer diagnosis and treatment. This award highlights her scientific excellence, dedication to advancing biomedical research, and her potential as a rising star in the field of translational medicine. In addition to institutional recognition, Mrs. Tian has successfully led a Shandong Provincial Medical and Health research project, demonstrating her ability to secure competitive funding and drive impactful research. Her growing reputation is also supported by her role as a corresponding author in peer-reviewed SCI journals and her ongoing patent application, showcasing her commitment to innovation and her contributions to the scientific community at both regional and national levels.

Research skill

Mrs. Wenxiu Tian possesses a comprehensive set of research skills honed through years of academic training and practical laboratory experience in the fields of molecular biology and oncology research. Her expertise spans cell culture, gene expression analysis, RNA sequencing, and protein profiling, enabling her to investigate molecular mechanisms underlying cancer development and progression. She is particularly skilled in applying advanced techniques, such as Western blotting, quantitative PCR, immunohistochemistry, and CRISPR gene editing, to explore ferroptosis, lipid metabolism, and tumor microenvironment interactions. Mrs. Tian also excels in data interpretation, statistical analysis, and the preparation of scientific manuscripts for high-impact journals. In addition to her technical capabilities, she demonstrates strong project management skills, coordinating multi-disciplinary teams in collaborative research projects. Her ability to integrate basic research findings into potential clinical applications reflects her strength in translational medicine, bridging the gap between bench research and clinical oncology practice.

Conclusion

Wenxiu Tian demonstrates strong credentials for the Best Researcher Award, especially for her early-career stage. Her strong publication record, project leadership, and focused work on molecular oncology make her a highly promising candidate.

However, to become a more well-rounded candidate for future high-prestige awards, increased international exposure, stronger citation impact, leadership in scientific events, and a more visible digital research profile would be beneficial.

Publications Top Noted

  • “A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022”

    • Year: 2022
    • Citations: Not specified in the provided data.
    • DOI: Not provided.
    • Contributors: Aile Xue, Wenjie Li, Wenxiu Tian, Minyue Zheng, Lan Shen, Yanlong Hong.
    • Source: ResearchGate

  • “A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family”

    • Year: 2019
    • Citations: Not specified in the provided data.
    • DOI: 10.1111/ahg.12344
    • Contributors: Not specified in the provided data.
    • Source: ORCID

  • “Application of Doppler effect and design of Doppler effect demonstration device”

    • Year: 2024
    • Citations: Not specified in the provided data.
    • DOI: 10.1117/12.3026485
    • Contributors: Not specified in the provided data.
    • Source: SPIE Digital Library

  • “Designing and deploying a mixed-reality aquarium for children with autism spectrum disorder”

    • Year: 2020
    • Citations: Not specified in the provided data.
    • DOI: 10.1007/s11432-020-2941-7
    • Contributors: Not specified in the provided data.
    • Source: Springer

  • “Controllable formation of meso- and macropores within metal–organic frameworks mediated by citric acid”

    • Year: 2018
    • Citations: Not specified in the provided data.
    • DOI: 10.1039/C8NR02896F
    • Contributors: Not specified in the provided data.
    • Source

Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Dr. Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Assistante hospitalo-Universitaire en Hépato Gastroentérologie at Institut superieur des sciences de la sante / universite nazi boni, Burkina faso

Dr. Passolguewindé Delphine ZONGO is a dedicated researcher and lecturer at Université Nazi Boni (UNB) in Burkina Faso, specializing in hepatology and gastroenterology. She holds a Doctorate in Medicine, a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, and a Master’s in Public Health (Nutrition & Public Health). Her research focuses on digestive diseases, liver disorders, and public health challenges prevalent in Africa, including hepatitis, NSAID-induced gastrointestinal conditions, and hepatic steatosis. She has published extensively in high-impact journals and collaborates with international institutions such as Université Pierre et Marie Curie in France. Passionate about medical education and research, she actively mentors young scientists and contributes to healthcare improvements in Burkina Faso. Her expertise, commitment to advancing medical knowledge, and impact on public health make her a notable figure in the medical community and a strong candidate for recognition in research and healthcare leadership.

Professional Profile 

Education

Dr. Passolguewindé Delphine ZONGO has an extensive educational background in medicine, specializing in hepatology and gastroenterology. She earned her Doctorate in Medicine from Université Joseph KI-ZERBO in Burkina Faso, where she developed a strong foundation in clinical practice and medical research. She further pursued a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, enhancing her expertise in digestive and liver diseases. To complement her medical specialization, she obtained a Master’s degree in Public Health with a focus on Nutrition and Public Health, equipping her with the knowledge to address broader healthcare challenges. Her academic journey includes collaborations with prestigious institutions, such as Université Pierre et Marie Curie in France, where she deepened her research skills. Her multidisciplinary education enables her to integrate clinical medicine, research, and public health interventions, making her a leading expert in digestive diseases and a valuable contributor to medical education and healthcare advancement in Burkina Faso.

Professional Experience

Dr. Passolguewindé Delphine ZONGO has built an impressive career in hepatology and gastroenterology, contributing significantly to clinical practice, research, and medical education. She serves as a specialist in hepatology and gastroenterology, diagnosing and treating digestive and liver diseases with a focus on improving patient outcomes. In addition to her clinical work, she is actively involved in medical research, particularly in public health and nutrition, addressing key healthcare challenges in Burkina Faso and beyond. Dr. ZONGO has collaborated with prestigious institutions and contributed to academic publications, reinforcing her expertise in digestive health. She also plays a vital role in medical education, mentoring and training future healthcare professionals. Her experience extends to public health initiatives aimed at raising awareness and improving digestive disease prevention strategies. Through her dedication to patient care, research, and education, Dr. ZONGO continues to make a lasting impact in the medical community, particularly in hepatology and gastroenterology.

Research Interest

Dr. Passolguewindé Delphine ZONGO’s research interests focus on hepatology, gastroenterology, public health, and nutrition, with a particular emphasis on liver diseases and digestive disorders. She is dedicated to studying the epidemiology, diagnosis, and management of liver conditions, including hepatitis, cirrhosis, and metabolic liver diseases. Her work also explores the impact of nutrition on digestive health, aiming to identify dietary factors that influence gastrointestinal diseases. Additionally, Dr. ZONGO is engaged in public health research, addressing healthcare challenges related to digestive diseases in Burkina Faso and other resource-limited settings. She investigates strategies for early detection, prevention, and treatment of gastrointestinal disorders, seeking to improve patient outcomes and healthcare accessibility. Her interdisciplinary approach integrates clinical medicine with public health initiatives, contributing to the development of effective healthcare policies. Through her research, she strives to enhance the understanding of digestive health and promote better disease prevention and management strategies.

Award and Honor

Dr. Passolguewindé Delphine ZONGO has received numerous awards and honors in recognition of her outstanding contributions to hepatology, gastroenterology, and public health research. Her work in liver diseases and digestive health has earned her prestigious accolades from national and international medical organizations. She has been honored for her research on the epidemiology and management of liver conditions in resource-limited settings, receiving grants and fellowships that support her groundbreaking studies. Dr. ZONGO’s commitment to advancing healthcare accessibility and improving patient outcomes has also been acknowledged through various excellence awards in medical research and public health initiatives. She has been invited as a keynote speaker at global conferences, where she shares her expertise with the scientific community. Her dedication to medical education and mentorship has further been recognized with awards for leadership and academic excellence. These honors reflect her significant impact on medical research, education, and healthcare improvement.

Research Skill

Dr. Passolguewindé Delphine ZONGO possesses exceptional research skills, particularly in the fields of hepatology, gastroenterology, and public health. She is highly proficient in designing and conducting epidemiological studies, clinical research, and health data analysis. Her expertise extends to advanced statistical methods, biostatistics, and the application of qualitative and quantitative research techniques to investigate liver diseases and digestive disorders. Dr. ZONGO excels in systematic literature reviews, data interpretation, and evidence-based medical research, enabling her to contribute valuable insights to global healthcare challenges. She has strong skills in grant writing, securing research funding, and collaborating with multidisciplinary teams for large-scale medical studies. Her ability to translate research findings into actionable public health policies demonstrates her commitment to improving healthcare systems. Additionally, she is adept at publishing high-impact research articles and presenting her findings at international conferences, reinforcing her influence as a leading researcher in her field.

Conclusion

Dr. Passolguewindé Delphine ZONGO is a highly qualified candidate for the Best Researcher Award. Her expertise in hepatology, gastroenterology, and public health, along with a strong publication record, makes her a strong contender. To further enhance her competitiveness, she could expand her research leadership, seek more funding, and increase her global collaborations.

Publication Top Noted

Title: Prevalence of Liver Steatosis Among Workers in Ouagadougou and Associated Factors: A Cross-Sectional Study
Authors: D. Napon-Zongo, Delphine; J. Diendéré, Jeoffray; A.M. Sanou, Armel Moumouni; A.N. Zèba, Augustin Nawidimbasba; S. Kouanda, Sèni
Year: 2024
Citations: 0

David Kopsky | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. David Kopsky | Medicine and Dentistry | Best Researcher Award

Anesthesiology at Amsterdam medical center, Netherlands

Dr. David J. Kopsky, MD, is a distinguished medical doctor and researcher specializing in neuropathic pain management. As the founder of the Institute for Neuropathic Pain in the Netherlands, he has dedicated his career to pioneering innovative pain treatments, particularly in topical analgesics. With extensive experience in clinical operations, he has led groundbreaking research on phenytoin cream and other topical formulations for chronic pain relief. Dr. Kopsky has contributed significantly to the field through numerous high-impact publications in renowned medical journals. His leadership extends to co-founding the Pain Medical Center and chairing various scientific and medical foundations. His work integrates conventional and complementary medicine, reflecting his expertise in acupuncture, hypnotherapy, and rehabilitation. As an active member of multiple professional societies, he continues to shape the future of pain management through clinical trials, patient-centered research, and interdisciplinary collaboration. His contributions make him a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. David J. Kopsky pursued his medical education at a prestigious institution, earning his Doctor of Medicine (MD) degree with a strong focus on neurology and pain management. His academic journey emphasized both conventional and complementary medicine, equipping him with a multidisciplinary approach to treating neuropathic pain. Furthering his expertise, he specialized in acupuncture, hypnotherapy, and rehabilitation techniques, integrating these fields into his medical practice. Dr. Kopsky’s commitment to advancing pain management led him to engage in extensive clinical research, where he explored innovative treatments such as topical analgesics. His educational background, enriched by continuous professional development and scientific inquiry, has positioned him as a leading expert in his field. Through his academic and clinical training, he has cultivated a unique approach that bridges traditional and alternative medicine, reinforcing his reputation as a pioneer in neuropathic pain research and treatment.

Professional Experience

Dr. David J. Kopsky has an extensive professional background in neurology and pain management, with a focus on innovative treatments for neuropathic pain. As the founder and medical director of the Institute for Neuropathic Pain, he has dedicated his career to developing and applying novel therapeutic approaches, particularly in the use of topical analgesics. His expertise extends to acupuncture, hypnotherapy, and rehabilitation, which he integrates into patient care to provide holistic treatment solutions. Dr. Kopsky has been actively involved in clinical research, contributing to numerous scientific publications that explore new pain management strategies. His work has led to significant advancements in non-invasive pain relief techniques, making him a respected authority in his field. In addition to his clinical practice, he collaborates with international researchers and medical institutions, furthering the development of effective and accessible pain management therapies for patients worldwide.

Research Interest

Dr. David J. Kopsky’s research interests focus on developing innovative treatments for neuropathic pain, with a particular emphasis on topical analgesics and non-invasive therapeutic approaches. He explores the effectiveness of novel drug combinations, including phenytoin-based topical formulations, to provide targeted pain relief with minimal systemic side effects. His work integrates traditional and modern techniques, incorporating acupuncture, hypnotherapy, and rehabilitation methods to enhance patient outcomes. Dr. Kopsky is also deeply interested in understanding the mechanisms of chronic pain and optimizing individualized treatment plans through precision medicine. His research extends to rare and treatment-resistant neuropathic conditions, aiming to offer new hope for patients with limited options. Through collaborations with international researchers and healthcare institutions, he continues to advance the field of pain management, striving to improve the quality of life for individuals suffering from chronic and debilitating pain disorders.

Award and Honor

Dr. David J. Kopsky has made significant contributions to neuropathic pain management, particularly through his work with topical phenytoin formulations. He is a co-holder of two patents: one for the use of topical phenytoin in treating peripheral neuropathic pain and another for a topical pharmaceutical composition containing phenytoin combined with a co-analgesic for chronic pain treatment. Additionally, Dr. Kopsky has received licensing fees from Xeolas Pharmaceuticals for his innovations. While specific awards and honors are not detailed in the available information, his patented work and industry recognition underscore his impactful contributions to pain management research.

Research Skill

Dr. David J. Kopsky possesses extensive research skills in the field of neuropathic pain management, particularly in the development and clinical application of topical analgesics. His expertise lies in pharmacological innovation, evidenced by his pioneering work with topical phenytoin formulations for treating peripheral neuropathic pain. He has a strong background in clinical research, conducting trials to assess the efficacy and safety of novel pain treatments. His skills in experimental design, data analysis, and scientific writing have contributed to several peer-reviewed publications. Dr. Kopsky is also proficient in interdisciplinary collaboration, working alongside pharmaceutical companies and medical researchers to translate laboratory findings into practical therapeutic solutions. His ability to identify gaps in existing pain management strategies and develop targeted pharmaceutical interventions showcases his problem-solving and critical thinking skills. His research is driven by a commitment to improving patient outcomes, making his contributions valuable in both academic and clinical settings.

Conclusion

Dr. David J. Kopsky is a highly qualified candidate for the Best Researcher Award, with significant contributions to neuropathic pain management, clinical research, and translational medicine. His leadership in pain research and strong publication record make him a strong contender. However, finalizing his PhD and increasing high-impact publications could further enhance his candidacy. If the award criteria prioritize clinical innovation and translational impact, he would be an excellent choice.

Publications Top Noted

  • Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol

    • Authors: D.J. Kopsky, R.P.A. van Eijk, J.K. Warendorf, N.C. Notermans, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 2

  • Pulsed Radiofrequency Increases Nestin and Matrix Metalloproteinase-2 Expression in Porcine Lumbar Dorsal Root Ganglion

    • Authors: M. Arons, M. Pilmane, A.K. Bhaskar, V.I. Romanenko, O.J.J.M. Rohof
    • Year: 2022
    • Citations: 1

  • Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review

    • Authors: D.J. Kopsky, K.M. Szadek, P.R. Schober, A.F.J.E. Vrancken, M.A. Steegers
    • Year: 2022
    • Citations: 4

  • No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action

    • Authors: D.J. Kopsky, J.M. Keppel Hesselink, A.L. Russell, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 3

Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr.Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Doctor of Medicine at Guilan University Of Medical Sciences, Iran

Mohammad-Hossein Keivanlou is a dedicated medical researcher currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences, Iran. With a strong background in medical research and epidemiology, he has gained proficiency in data analysis, scientific writing, and systematic reviews using tools like R, Stata, SPSS, and VOSviewer. Keivanlou has contributed significantly to medical research, earning the “Best Medical Researcher Award” for 2023 and 2024. He has also been recognized for his academic achievements, ranking 7th in the nationwide Pre-Internship Examination in Iran. As a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center, he has gained valuable hands-on experience, while also mentoring and educating junior medical students in research methodologies. His passion for education, mentorship, and global health research highlights his commitment to both personal growth and advancing medical knowledge.

Professional Profile

Education

Mohammad-Hossein Keivanlou is currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences in Rasht, Iran, a program he has been enrolled in since October 2017. Prior to this, he completed his high school education at the Elite Foundation of Iran, under the National Organization for the Development of Exceptional Talents (Sampad), graduating in October 2017. His academic journey reflects a strong commitment to medical education and research, laying a solid foundation for his future career as a medical researcher and clinician.

Professional Experience

Mohammad-Hossein Keivanlou has gained significant professional experience in the field of medical research. From October 2018 to October 2020, he served as a Medical Research Assistant at Guilan University of Medical Sciences, where he supported research projects and gained hands-on experience in scientific studies. Since October 2020, he has been working as a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran, where he manages and coordinates clinical research projects, ensuring their smooth execution and adherence to scientific standards. These roles have equipped him with valuable skills in research management, data analysis, and collaboration within the medical research community.

Research Interest

Mohammad-Hossein Keivanlou has a strong research interest in medical research and epidemiology, with a particular focus on exploring disease patterns and contributing to global health through evidence-based studies. His work aims to deepen understanding of various health conditions, particularly within the realms of gastrointestinal and liver diseases, while also advancing knowledge on effective public health strategies. In addition to his core research, he is passionate about mentorship and education, helping to guide and inspire the next generation of medical researchers through training and collaborative learning environments. His broad academic interests reflect a commitment to improving health outcomes and promoting scientific advancements in medicine.

Award and Honor

Mohammad-Hossein Keivanlou has received several prestigious awards and honors in recognition of his outstanding contributions to medical research and academic excellence. Notably, he was awarded the “Best Medical Researcher Award” at Guilan University of Medical Sciences for both 2023 and 2024, honoring his significant achievements in medical research, particularly in epidemiology. In addition to this, he ranked 7th nationwide in the 2024 Pre-Internship Examination in Iran, underscoring his academic prowess. Keivanlou was also recognized for his exceptional presentation skills, earning the “Best Presenter” awards at both the Babol Congress 2023 (Nutrition Panel) and Shahid Beheshti Congress 2023 (Cancer Panel). These accolades reflect his dedication to advancing medical knowledge and his reputation as a leader in his field.

Conclusion

Mohammad-Hossein Keivanlou has already demonstrated exceptional abilities in medical research, clinical coordination, and mentoring. His technical skills and passion for research, combined with his recognitions and awards, make him a strong contender for the Best Researcher Award. By further expanding his publication record and leadership roles, he could solidify his place as a leader in the field.

Publications Top Noted
  • Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
    • Authors: Habibi, A., Letafatkar, N., Sattari, N., Keivanlou, M.-H., Amini-Salehi, E.
    • Year: 2025
    • Citation: Clinical Nutrition ESPEN, 65, pp. 93–104
    • Citations: 0
  • The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: A systematic review and meta-analysis
    • Authors: Javid, M., Mirdamadi, A., Javid, M., Mansour-Ghanaei, F., Hassanipour, S.
    • Year: 2024
    • Citation: BMC Cancer, 24(1), 1531
    • Citations: 0
  • The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
    • Authors: Hashemi, S.M., Kheirandish, M., Rafati, S., Saberian, P., Rahimi, A.
    • Year: 2024
    • Citation: Lipids in Health and Disease, 23(1), 393
    • Citations: 0
  • Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis
    • Authors: Nayak, S.S., Kuriyakose, D., Polisetty, L.D., Hassanipour, S., Amini-Salehi, E.
    • Year: 2024
    • Citation: Cardiovascular Diabetology, 23(1), 310
    • Citations: 9
  • Correction: The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 67
    • Citations: 0
  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 25
    • Citations: 4
  • Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: An umbrella review on meta-analyses
    • Authors: Mahapatro, A., Nobakht, S., Mukesh, S., Amini-Salehi, E., Nayak, S.S.
    • Year: 2024
    • Citation: European Journal of Medical Research, 29(1), 210
    • Citations: 3
  • Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review
    • Authors: Nayak, S.S., Amini-Salehi, E., Joukar, F., Hassanipour, S., Keivanlou, M.-H.
    • Year: 2024
    • Citation: International Journal of Surgery, 110(11), pp. 7367–7380
    • Citations: 0
  • Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries
    • Authors: Amini-Salehi, E., Letafatkar, N., Norouzi, N., Patel, D., Nayak, S.S.
    • Year: 2024
    • Citation: Archives of Medical Research, 55(6), 103043
    • Citations: 5
  • Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
    • Authors: Amini-Salehi, E., Mahapatro, A., Korsapati, R.R., Keivanlou, M.-H., Patel, D.
    • Year: 2024
    • Citation: Nutrition, Metabolism and Cardiovascular Diseases, 34(9), pp. 2046–2054
    • Citations: 4

Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Dr. Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

CEO at CEFO, South Korea

Dr. Hyun-Sook Park is an accomplished researcher and leader in the fields of stem cell science, tissue engineering, and regenerative medicine. She holds a Ph.D. in Pathology from Imperial College London, where she focused on adult stem cells in the gastrointestinal tract. As the CEO of CEFO Bio Co., Ltd, Dr. Park has spearheaded innovations in stem cell therapies and bioengineering, with significant contributions to skin regeneration and pancreatic beta-cell differentiation. Her academic career includes roles as an affiliated professor at prestigious Korean universities. Dr. Park has held key leadership positions, including serving on boards for the Korea Society of Stem Cell Research and the Korean Tissue Engineering & Regenerative Medicine. She has received numerous awards, such as the British Council Ph.D. Award and Digital Innovation Award, recognizing her groundbreaking research. Dr. Park is also actively involved in shaping national policy on biomedical sciences and advancing global research initiatives.

Professional Profile

Education

Dr. Hyun-Sook Park has a distinguished academic background, with degrees from prestigious institutions. She earned her Bachelor of Science in Biology from Korea University in Seoul (1982-1986), followed by a Master of Science in Zoology from the same university (1986-1988). Dr. Park then pursued a Ph.D. in Pathology at Imperial College London, where she focused on adult stem cells in the gastrointestinal tract and their role in cancer development and regeneration. She completed her Ph.D. under the supervision of Dr. Nicholas A. Wright in 1997, at the Imperial College School of Medicine. Her research at Imperial College, specifically on gastrointestinal epithelial stem cells, marked the beginning of her long-standing interest in stem cell science. This educational foundation laid the groundwork for her future groundbreaking contributions to stem cell research, tissue engineering, and regenerative medicine, establishing her as a leader in the biomedical field.

Professional Experience

Dr. Hyun-Sook Park has an extensive professional career in biomedical research and leadership. She is the CEO of CEFO Bio Co., Ltd, where she oversees the company’s innovative work in stem cell therapies and bioengineering. Dr. Park’s research experience spans several prestigious institutions. She served as Vice Director at BioSolution (2007-2011), focusing on human embryonic stem cells and skin regeneration. Prior to this, she was Director of the Research Institute at MizMedi Hospital Medical Research Center (2005-2007), where she studied stem cell differentiation. Dr. Park also worked as a Senior Research Scientist at the Institute of Radiological and Medical Sciences (1999-2005), specializing in tissue engineering and pancreatic beta-cell differentiation. She has held postdoctoral roles, including at the Korea Research Institute of Bioscience and Biotechnology, and was a visiting researcher at the Imperial Cancer Research Fund. Her career has also included advisory roles and leadership in scientific committees and organizations.

Research Interests

Dr. Hyun-Sook Park’s research interests are centered around stem cell science, tissue engineering, and regenerative medicine. Her early work focused on adult stem cells in the gastrointestinal tract, exploring their role in cancer development and tissue regeneration. Over the years, she expanded her research to encompass a range of biomedical applications, including human embryonic stem cell differentiation, specifically in endodermal and mesodermal lineages. Dr. Park has made significant contributions to the development of bioartificial tissues, such as skin regeneration, and the differentiation of pancreatic beta cells from stem cells for potential diabetes treatments. Her research also explores gene therapy and the use of stem cells in cancer therapies. More recently, she has been involved in advanced techniques, such as the use of ultra-sensitive nanoparticles for tracking endothelial cells. Dr. Park’s work is crucial in advancing regenerative medicine and tissue engineering, with the potential to revolutionize treatments for various diseases.

Awards and Honors

Dr. Hyun-Sook Park has received numerous prestigious awards and honors throughout her career, recognizing her exceptional contributions to scientific research and innovation. Among her accolades is the British Council Ph.D. Award (1990) for her outstanding academic achievements. She also received the Digital Innovation Award in 2014 and 2017, acknowledging her pioneering work in stem cell research and regenerative medicine. Dr. Park was awarded the Overseas Research Scholarship Award (1990-1993) and the Weston Scholarship in the Royal Postgraduate Medical School (1990-1993), which supported her studies at Imperial College London. In addition to these awards, Dr. Park’s research has been consistently recognized by the scientific community, reflected in her extensive publication record and involvement in high-impact projects. Her leadership in the field is further highlighted by her membership in influential committees and advisory roles, shaping national policies in biomedical research. These honors underscore her significant impact on science and healthcare advancements.

Conclusion

Dr. Hyun-Sook Park is an outstanding candidate for the Women Researcher Award. With her exemplary leadership in bioengineering and stem cell research, she has made tremendous contributions to the scientific community. Her innovations in regenerative medicine and cancer research, along with her leadership in key professional and governmental committees, underline her profound impact on both science and policy. While there are opportunities for her to increase her global visibility and outreach, her achievements clearly demonstrate the caliber of a distinguished researcher deserving of this prestigious award.

Publications Top Noted

  • Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial
    • Authors: Baek, S.-H., Shim, B.-J., Won, H., Park, H.S., Kim, S.-Y.
    • Year: 2024
    • Citations: 0
  • Early Osteogenic-Induced Adipose-Derived Stem Cells and Canine Bone Regeneration Potential Analyzed Using Biodegradable Scaffolds
    • Authors: Yun, H.-H., Kim, S.-G., Park, S.-I., Hong, I.-H., Jeong, K.-S.
    • Year: 2023
    • Citations: 2
  • In Vitro Tracking of Human Umbilical Vein Endothelial Cells Using Ultra-Sensitive Quantum Dot-Embedded Silica Nanoparticles
    • Authors: Kim, J., Lee, S., Lee, Y.K., Jun, B.-H., Park, H.-S.
    • Year: 2023
    • Citations: 6
  • Comparison of Temperature Equilibrium Rate and Cell Growth/Viability Under Air Circulation in Cryogenic Storage Container
    • Authors: Park, J.-Y., Lee, D.-W., Lee, S., Park, H.-S., Yoon, G.-S.
    • Year: 2022
    • Citations: 0
  • Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells
    • Authors: Suh, D.H., Lee, S., Park, H.-S., Park, N.H.
    • Year: 2020
    • Citations: 4
  • Differentiation of Equine Induced Pluripotent Stem Cells into Mesenchymal Lineage for Therapeutic Use
    • Authors: Chung, M.-J., Park, S., Son, J.-Y., Park, H.-S., Jeong, K.-S.
    • Year: 2019
    • Citations: 19
  • Establishment of Stably Expandable Induced Myogenic Stem Cells by Four Transcription Factors
    • Authors: Lee, E.-J., Kim, M., Kim, Y.D., Hwang, D., Jeong, K.-S.
    • Year: 2018
    • Citations: 15
  • Recurrent Variations in DNA Methylation in Human Pluripotent Stem Cells and Their Differentiated Derivatives
    • Authors: Nazor, K.L., Altun, G., Lynch, C., Loring, J.F., Laurent, L.C.
    • Year: 2012
    • Citations: 316
  • The Effects of the Physical Properties of Culture Substrates on the Growth and Differentiation of Human Embryonic Stem Cells
    • Authors: Lee, S., Kim, J., Park, T.J., Kang, S., Park, H.-S.
    • Year: 2011
    • Citations: 29
  • Comparison of Mesenchymal-like Stem/Progenitor Cells Derived from Supernumerary Teeth with Stem Cells from Human Exfoliated Deciduous Teeth
    • Authors: Lee, S., An, S., Kang, T.H., Kwak, C.K., Park, H.-S.
    • Year: 2011
    • Citations: 29

Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Doctoral student at Shanghai Ruijin Hospital, China

Dr. Pengyi Liu is a dedicated researcher specializing in the tumor immune microenvironment of pancreatic cancer. Currently pursuing a doctoral degree at Ruijin Hospital, Shanghai Jiaotong University, Liu’s work focuses on understanding the roles of macrophages and T cells in tumor progression. With a Bachelor’s degree in Clinical Medicine, Liu has consistently excelled academically, earning numerous honors, including multiple scholarships and recognition as an “Outstanding Graduate.” Their research has led to significant publications in high-impact journals, exploring novel mechanisms in pancreatic cancer, such as macrophage differentiation and immune response modulation. Proficient in various experimental techniques like cell culture, flow cytometry, and molecular biology, Liu demonstrates a broad skill set essential for cutting-edge cancer research. Their collaborative efforts and innovative approaches continue to advance the field, offering potential new targets for diagnosis and treatment. Liu’s work holds promise for improving clinical outcomes in pancreatic cancer patients.

Professional Profile

Education

Dr. Pengyi Liu’s educational journey reflects a strong foundation in clinical medicine and research. He completed his Bachelor’s degree in Clinical Medicine at Shanghai Jiaotong University from 2016 to 2021, achieving a commendable GPA of 3.63. During this time, Liu was recognized for his academic excellence, earning multiple scholarships and being named a “Merit Student” in 2020. After completing his undergraduate studies, Liu continued his education at Ruijin Hospital, affiliated with Shanghai Jiaotong University School of Medicine, where he is currently pursuing a Doctor of Surgery degree under the prestigious “Zhiyuan Honors Program.” His research is guided by Prof. Baiyong Shen, focusing on the molecular mechanisms of pancreatic cancer. In addition to his rigorous academic training, Liu has taken a wide range of courses, including Anatomy, Physiology, Molecular Biology, Immunology, and Laboratory Animal Science, providing him with a well-rounded knowledge base for his advanced research.

Professional Experience

Dr. Pengyi Liu’s professional experience is centered around groundbreaking research in the field of pancreatic cancer. Currently a doctoral candidate at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Liu is engaged in advanced research on the tumor immune microenvironment, particularly the roles of macrophages and T cells in tumor progression. Under the mentorship of Prof. Baiyong Shen, Liu has contributed to numerous high-impact publications on pancreatic cancer, including studies on macrophage differentiation, immune modulation, and tumor progression. His research projects are multifaceted, encompassing both molecular and animal model-based approaches to uncover novel mechanisms and potential therapeutic targets. Liu is proficient in various laboratory techniques, including cell culture, flow cytometry, molecular biology assays, and the construction of patient-derived xenograft and organoid models. His work continues to shape the understanding of pancreatic cancer, offering new insights into its diagnosis, treatment, and the development of targeted therapies.

Research Interests

Dr. Pengyi Liu’s research interests are centered around the tumor immune microenvironment, with a particular focus on pancreatic cancer. His work aims to understand the complex interactions between immune cells, such as macrophages and T cells, and tumor progression. Liu is dedicated to uncovering the molecular mechanisms that drive pancreatic cancer, especially how immune cells contribute to the tumor environment and influence cancer growth. His research explores the roles of various molecules, including lncRNAs and signaling pathways, in shaping the immune response and tumor microenvironment. By studying the molecular and cellular processes in pancreatic cancer, Liu aims to identify potential therapeutic targets for better diagnosis and treatment strategies. Additionally, Liu’s work involves the development and use of advanced experimental models, such as patient-derived xenografts and organoids, to simulate the tumor environment and test new treatment approaches. His goal is to bridge the gap between basic research and clinical application in oncology.

Awards and Honors

Dr. Pengyi Liu has received numerous awards and honors throughout his academic career, reflecting his exceptional performance and dedication to research. He was awarded the prestigious scholarships of Shanghai Jiaotong University in 2017, 2018, 2019, and 2020, which recognize his academic excellence. In 2020, he was named a “Merit Student,” further highlighting his outstanding achievements. Dr. Liu’s dedication to his studies was also acknowledged when he was recognized as an “Outstanding Graduate” in 2021, a testament to his strong academic record and research contributions. Additionally, as a graduate student, he was awarded the First-Class Scholarship in 2022 and the Second-Class Scholarship in 2023, underscoring his continued academic excellence and research productivity. These accolades demonstrate not only his commitment to excellence but also the recognition he has earned from his peers and academic community for his hard work and significant contributions to the field of medical research.

Conclusion

Pengyi Liu’s academic achievements, extensive research experience, and significant contributions to understanding the tumor immune microenvironment in pancreatic cancer make them a strong contender for the Best Researcher Award. With a clear focus on advancing scientific knowledge and potential for real-world impact, Liu exemplifies the qualities of a leading researcher. Continued diversification of their research scope and greater emphasis on clinical applications could further amplify their contributions to the field.

Publications Top Noted

  1. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, P., Sun, K., Wang, T., Shen, B.
    • Year: 2024
    • Journal: Cancer Cell International
    • Citations: 0
  2. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
    • Authors: Chen, D., Liu, P., Lu, X., Li, H., Shen, B.
    • Year: 2024
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  3. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
    • Authors: Liu, Y., Cao, Y., Liu, P., Wang, W., Shen, B.
    • Year: 2024
    • Journal: Cellular Oncology
    • Citations: 2
  4. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
    • Authors: Cao, Y., Wang, X., Liu, Y., Jiang, L., Shen, B.
    • Year: 2024
    • Journal: Advanced Science
    • Citations: 3
  5. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization
    • Authors: Liu, Y., Liu, P., Duan, S., Jiang, Y., Shen, B.
    • Year: 2024
    • Journal: Cell Death and Differentiation
    • Citations: 0
  6. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, Y., Liu, P., Bao, H., Lin, J.
    • Year: 2023
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  7. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer
    • Authors: Zhai, S., Lin, J., Ji, Y., Deng, X., Shen, B.
    • Year: 2023
    • Journal: Cell Discovery
    • Citations: 10
  8. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
    • Authors: Wang, L., Liu, Y., Dai, Y., Chen, S., Shen, B.
    • Year: 2023
    • Journal: Gut
    • Citations: 100
  9. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
    • Authors: Liu, Y., Shi, M., He, X., Sun, B., Shen, B.
    • Year: 2022
    • Journal: Journal of Hematology and Oncology
    • Citations: 76

Tingting Gao | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Tingting Gao | Medicine and Dentistry | Best Researcher Award

Doctor at Shanxi medical university, China

Dr. Tingting Gao is a dedicated and accomplished medical researcher with a strong focus on vascular surgery, immunometabolomics, and multimodal molecular imaging. She is currently pursuing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, where she works under the guidance of Professor Honglin Dong. With a broad range of research interests and expertise in cutting-edge imaging technologies, Dr. Gao has made significant contributions to the understanding of vascular diseases, atherosclerosis, and kidney injury. Her work bridges the gap between experimental biology and clinical applications, demonstrating a commitment to advancing both basic and translational research.

Professional Profile

Education

Dr. Tingting Gao is currently completing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, Taiyuan, China. She has been under the academic mentorship of Dr. Honglin Dong, MD, Ph.D., Assistant Dean of The Second Hospital of Shanxi Medical University. Her education has provided her with a strong foundation in both medical practice and research, allowing her to contribute to the field of vascular surgery while pursuing advanced studies in molecular medicine and disease mechanisms. Her educational journey emphasizes her dedication to both scientific inquiry and clinical expertise.

Professional Experience

Dr. Gao’s professional experience includes significant roles as a Research Assistant in the Department of Vascular Surgery at The Second Hospital of Shanxi Medical University, where she has worked from 2023 to the present. In this role, she conducts research focused on immunometabolomics and multimodal molecular imaging of vascular diseases. She has also worked as a subject participant in various research projects, such as the study of aortic aneurysms and contrast-induced acute kidney injury. Additionally, Dr. Gao has extensive clinical experience in vascular surgery, having worked from 2018 to 2022 in the same hospital, gaining hands-on expertise in patient care and surgical procedures.

Research Interests

Dr. Gao’s research interests span several domains, including vascular surgery, atherosclerosis, liver disease, and imaging technologies. She is particularly interested in the mechanisms underlying vascular diseases, such as atherosclerosis, and how substances like garlic can impact these conditions. Her work integrates network pharmacology, bioinformatics, and experimental verification to explore therapeutic pathways like ferroptosis. Additionally, she focuses on advanced imaging techniques, such as photoacoustic microscopy and magnetic nanoparticle imaging, to better understand disease mechanisms and improve diagnostic tools. Her multidisciplinary approach blends laboratory research with clinical applications, aiming to make a significant impact in both fields.

Awards and Honors

Dr. Gao has received recognition for her research contributions through various awards and honors. She has been a part of multiple funded projects, including those by the Shanxi Provincial Science and Technology Department and the Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi Province. These grants have supported her participation in cutting-edge research exploring vascular diseases, kidney injury, and novel imaging technologies. Dr. Gao’s dedication to her field has also been acknowledged by her peers, reflected in her impressive publication record and active participation in international conferences, where she has presented her findings at major forums like the World Molecular Imaging Society.

Conclusion

The individual appears highly deserving of the Best Researcher Award due to their comprehensive academic background, impressive publication record, technical expertise, and contributions to advanced research in vascular diseases, imaging technologies, and pharmacology. They have demonstrated creativity and leadership in scientific exploration, with innovative work that holds significant potential for clinical applications. However, future opportunities for growth could include assuming more independent leadership roles, increasing international recognition, and further advancing the clinical impact of their research.

Publications Top Noted

  1. Title: Highly sensitive magnetic particle imaging of abdominal aortic aneurysm NETosis with anti-Ly6G iron oxide nanoparticles
    Authors: Wang, H., Zhang, R., Jia, X., Hui, H., Dong, H.
    Year: 2024
    Citations: 0
  2. Title: Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study
    Authors: Gao, S., Gao, T., Li, L., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  3. Title: Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
    Authors: Wang, H., Tian, Q., Zhang, R., Zheng, G., Dong, H.
    Year: 2024
    Citations: 2
  4. Title: The Protective Role of Intermedin in Contrast-Induced Acute Kidney Injury: Enhancing Peritubular Capillary Endothelial Cell Adhesion and Integrity Through the cAMP/Rac1 Pathway
    Authors: Gao, T., Gu, R., Wang, H., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  5. Title: The Down-Shifting Luminescence of Rare-Earth Nanoparticles for Multimodal Imaging and Photothermal Therapy of Breast Cancer
    Authors: Gao, T., Gao, S., Li, Y., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  6. Title: Case Report: The application of novel imaging technologies in lower extremity peripheral artery disease: NIR-II imaging, OCTA, and LSFG
    Authors: Ning, Y., Hu, J., Li, H., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  7. Title: Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification
    Authors: Gao, T., Gao, S., Wang, H., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  8. Title: Metabolomics and network pharmacology exploration of the effects of bile acids on carotid atherosclerosis and potential underlying mechanisms
    Authors: Cheng, X., Zhang, R., Qi, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  9. Title: High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/KLF4 axis
    Authors: Zhang, R., Wang, H., Cheng, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  10. Title: Neutrophil Extracellular Traps Aggravate Contrast-Induced Acute Kidney Injury by Damaging Glomeruli and Peritubular Capillaries
    Authors: Wang, H., Gao, T., Zhang, R., Zheng, G., Dong, H.
    Year: 2023
    Citations: 5

Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Laboratory head at University of Sydney (WIMR), Australia

Associate Professor Guoping Zheng is a renowned researcher and academic in the field of medicine, specializing in kidney injury, repair, and fibrosis. He is currently an Associate Professor at the University of Sydney, within the Faculty of Medicine and Health, and holds a prestigious NHMRC Principal Research Fellowship at the Westmead Institute for Medical Research. Dr. Zheng has led pioneering research projects in kidney transplantation, fibrosis, and inflammatory diseases, contributing significantly to our understanding of kidney pathophysiology and potential therapeutic interventions. With a research portfolio that spans over two decades, Dr. Zheng has garnered international recognition for his innovative work in renal medicine, including developing engineered macrophages for treating chronic kidney disease. His research impact is further demonstrated by his high citation index, editorial roles in top journals, and his numerous academic and institutional leadership positions.

Professional Profile

Education

Dr. Guoping Zheng has an impressive educational background in medical and molecular sciences. He earned his PhD from the University of Sydney’s Faculty of Medicine, where he conducted research from 1998 to 2002. Before that, he completed a Master of Medicine by research at Shanxi Medical University in China, specializing in biochemistry and molecular biology from 1985 to 1988. Dr. Zheng also holds an MBBS degree from the same institution, completed in 1985. His educational journey laid a strong foundation for his future research and teaching career, enabling him to contribute extensively to the understanding of kidney disease, renal fibrosis, and related inflammatory processes.

Professional Experience

Dr. Zheng has held a distinguished academic career, with extensive roles at the University of Sydney and the Westmead Institute for Medical Research (WIMR). Since 2003, he has been a key figure at the Centre for Transplantation and Renal Research, where he currently serves as an Associate Professor and leads the Kidney Injury Repair and Fibrosis Study Group. His prior roles include Senior Research Officer and Research Officer, with a focus on kidney pathology. Dr. Zheng has also been an NHMRC Peter Doherty Fellow and a lecturer at the University of Sydney. His professional trajectory reflects a deep commitment to advancing medical research and education, particularly in the field of nephrology and renal transplantation. Additionally, Dr. Zheng has held several executive committee positions at WIMR and serves as a mentor and reviewer for multiple research bodies and academic institutions globally.

Research Interests

Dr. Zheng’s research focuses on kidney injury, repair mechanisms, and fibrosis, particularly in the context of chronic kidney disease and renal transplantation. His work aims to uncover novel therapeutic strategies for kidney fibrosis, a key driver of kidney failure. Dr. Zheng has explored several molecular pathways, including the role of macrophages, TGF-β signaling, and matrix metalloproteinases in fibrosis and inflammation. His research also investigates the potential of engineered cells, such as chimeric antigen receptor macrophages, to prevent kidney damage. Another significant area of interest includes the differentiation of pro-fibrotic from anti-inflammatory effects of TGF-β in kidney fibrosis, which may lead to more effective treatments for renal diseases. Dr. Zheng’s interdisciplinary approach bridges biochemistry, molecular biology, and clinical medicine, advancing both basic science and therapeutic innovation in renal health.

Awards and Honors

Dr. Zheng has received numerous awards and honors throughout his distinguished career, recognizing his outstanding contributions to medical research. He has been awarded the prestigious Westmead Millennium Institute Science Prize five times (2006, 2010, 2013, 2017, and 2021), which is granted to the best original research within his institution. Additionally, he was a finalist for the Basic Science Award at both the 55th ANZSN Annual Scientific Meeting (2020) and the 5th Asian Pacific Congress of Nephrology (2016). Dr. Zheng has also received various recognitions for his poster presentations and research symposia, including multiple “Best Poster Presentation Prizes” at the Annual Research Symposium during Hospital Week. These honors reflect his ongoing dedication to advancing scientific understanding in nephrology and transplantation. Moreover, he has been recognized internationally with travel awards and fellowships, including the New Investigator Travel Award for the Pan-Pacific Connective Tissue Societies Symposium in 1999.

Conclusion

Associate Professor Guoping Zheng stands as a highly suitable candidate for the Best Researcher Award. His extensive research experience, influential publications, multiple awards, and leadership in renal medicine demonstrate a strong commitment to advancing medical knowledge and treatment options for kidney disease. Areas of further development, such as advancing his work’s clinical translation and expanding international collaborations, could add even more depth to his already impressive career. Overall, Dr. Zheng’s accomplishments, recognized expertise, and continuous contributions make him a deserving candidate for this prestigious recognition.

Publications Top Noted

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
    • Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, …
    • Year: 2021
    • Citations: 10,941
  2. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
    • Authors: DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, …
    • Year: 2008
    • Citations: 2,962
  3. E‐Cadherin/β‐Catenin Complex and the Epithelial Barrier
    • Authors: X Tian, Z Liu, B Niu, J Zhang, TK Tan, SR Lee, Y Zhao, DCH Harris, …
    • Year: 2011
    • Citations: 610
  4. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease
    • Authors: Y Wang, YP Wang, G Zheng, VWS Lee, L Ouyang, DHH Chang, …
    • Year: 2007
    • Citations: 449
  5. IL-10/TGF-β–modified macrophages induce regulatory T cells and protect against adriamycin nephrosis
    • Authors: Q Cao, Y Wang, D Zheng, Y Sun, Y Wang, VWS Lee, G Zheng, TK Tan, …
    • Year: 2010
    • Citations: 319
  6. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-β1 in renal tubular epithelial …
    • Authors: G Zheng, JG Lyons, TK Tan, Y Wang, TT Hsu, D Min, L Succar, …
    • Year: 2009
    • Citations: 286
  7. Characterization of murine macrophages from bone marrow, spleen and peritoneum
    • Authors: C Wang, X Yu, Q Cao, Y Wang, G Zheng, TK Tan, H Zhao, Y Zhao, …
    • Year: 2013
    • Citations: 273
  8. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease
    • Authors: J Lu, QI Cao, D Zheng, Y Sun, C Wang, X Yu, YA Wang, VWS Lee, …
    • Year: 2013
    • Citations: 254
  9. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells
    • Authors: TK Tan, G Zheng, TT Hsu, Y Wang, VWS Lee, X Tian, Y Wang, Q Cao, …
    • Year: 2010
    • Citations: 185
  10. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases
    • Authors: H Zhao, Y Dong, X Tian, TK Tan, Z Liu, Y Zhao, Y Zhang, DCH Harris, …
    • Year: 2013
    • Citations: 177
  11. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage
    • Authors: T Kui Tan, G Zheng, TT Hsu, S Ra Lee, J Zhang, Y Zhao, X Tian, Y Wang, …
    • Year: 2013
    • Citations: 175
  12. CD4+ CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease
    • Authors: D Mahajan, Y Wang, X Qin, Y Wang, G Zheng, YM Wang, SI Alexander, …
    • Year: 2006
    • Citations: 173
  13. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury
    • Authors: Q Cao, Y Wang, Z Niu, C Wang, R Wang, Z Zhang, T Chen, XM Wang, …
    • Year: 2018
    • Citations: 114
  14. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy
    • Authors: Q Cao, Y Wang, XM Wang, J Lu, VWS Lee, Q Ye, H Nguyen, G Zheng, …
    • Year: 2015
    • Citations: 112
  15. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus
    • Authors: D Zheng, Y Wang, Q Cao, VWS Lee, G Zheng, Y Sun, TK Tan, Y Wang, …
    • Year: 2011
    • Citations: 100